Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Fatigue in patients with multiple sclerosis: is it related to pro- and anti-inflammatory cytokines?
Altered transition metal homeostasis in the cuprizone model of demyelination.
Synthesis and Evaluation of Fluorinated Fingolimod (FTY720) Analogues for Sphingosine-1-Phosphate Receptor Molecular Imaging by Positron Emission Tomography.
Analytical performances of SPAPLUS® turbidimeter for the quantification of albumin and IgG in serum and cerebrospinal fluid.
Fingolimod for relapsing-remitting multiple sclerosis.
Clinical neurophysiology of multiple sclerosis.
Energy expenditure during everyday activities - a study comparing people with varying mobility limitations due to multiple sclerosis and healthy controls.
Gender influence on schizophrenia-relevant abnormalities in a cuprizone demyelination model.
Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor.
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane.
Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
Clinical association of intrathecal and mirrored oligoclonal bands in paediatric neurology.
Bradykinin type 2 receptor -9/-9 genotype is associated with triceps brachii muscle hypertrophy following strength training in young healthy men.
Cognitive Impairment Occurs in Children and Adolescents With Multiple Sclerosis: Results From a United States Network.
Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
VIP and PACAP: Neuropeptide modulators of CNS inflammation, injury, and repair.
White matter disease: Early treatment of inflammatory demyelinating disease.
Erythropoietin (EPO) increases myelin gene expression in CG4 oligodendrocyte cells through the classical EPO receptor.
[Optic nerve neuritis].
The Promoter SNP, but not the Alternative Splicing SNP, is Linked to Multiple Sclerosis Among Jordanian Patients.

Pages